ANIK Q1 2025 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$26M-35.4% YoY

Gross Profit

$15M56.1% margin

Operating Income

-$4M-16.4% margin

Net Income

-$5M-18.6% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+2128.5%

Cash Flow

Operating Cash Flow

-$130,000

Free Cash Flow

-$3M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$191M

Total Liabilities

$42M

Stockholders' Equity

$148M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$41M	-35.4%
Gross Profit	$15M	$25M	-40.4%
Operating Income	-$4M	-$5M	+15.4%
Net Income	-$5M	-$5M	-8.0%

Geographic Segments

UNITED STATES

$16M74%

Europe

$6M26%